Corning (GLW) to pay $0.20 on Mar 29, 2019; Zimmer Biomet Holdings (ZBH) Sellers Decreased By 17.8% Their Shorts

Corning Incorporated (NYSE:GLW) Logo

Corning Inc (NYSE:GLW) is expected to pay $0.20 on Mar 29, 2019. (NYSE:GLW) shareholders before Feb 27, 2019 will receive the $0.20 dividend. Corning Inc’s current price of $34.04 translates into 0.59% yield. Corning Inc’s dividend has Feb 28, 2019 as record date. Feb 7, 2019 is the announcement. The stock increased 0.06% or $0.02 during the last trading session, reaching $34.04. About 3.88M shares traded. Corning Incorporated (NYSE:GLW) has risen 0.09% since February 14, 2018 and is uptrending. It has outperformed by 0.09% the S&P500. Some Historical GLW News: 02/04/2018 – Corning Named 2018 ENERGY STAR® Partner of the Year; 24/04/2018 – Corning Presenting at JPMorgan Conference May 16; 26/04/2018 – CORNING INC GLW.N SETS QUARTERLY DIVIDEND OF $0.18/SHR; 29/03/2018 – Air Products’ Industrial Gases Executive Vice President Corning Painter Provides Thought Leadership on Coal Gasification at China Petroleum and Chemical Industry Federation Dialogue in Beíjing; 24/04/2018 – CORNING INC – COMPANY EXPECTS YEAR-OVER-YEAR SALES GROWTH FOR SPECIALTY MATERIALS IN 2018; 30/05/2018 – Corning Presenting at AllianceBernstein Conference Tomorrow; 24/05/2018 – Moody’s Assigns Aa3 And Mig 1 To Corning Csd, Ny’s 2018 Go Bonds And Bans; 12/03/2018 – Corning TXF(TM) Optical Fiber Advances Next Generation Long-Haul Networks; 29/03/2018 – Air Products’ Industrial Gases Executive Vice President Corning Painter Provides Thought Leadership on Coal Gasification at Chi; 20/04/2018 – Arkansas DoH: ADH Warns of Possible Hepatitis A Exposure to Customers of Corning, Ark., Flash Market/Subway

Zimmer Biomet Holdings Inc (NYSE:ZBH) had a decrease of 17.8% in short interest. ZBH’s SI was 2.73M shares in February as released by FINRA. Its down 17.8% from 3.33 million shares previously. With 1.11M avg volume, 3 days are for Zimmer Biomet Holdings Inc (NYSE:ZBH)’s short sellers to cover ZBH’s short positions. The stock decreased 0.31% or $0.39 during the last trading session, reaching $123.56. About 981,356 shares traded. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has declined 3.21% since February 14, 2018 and is downtrending. It has underperformed by 3.21% the S&P500. Some Historical ZBH News: 19/03/2018 – Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations; 25/04/2018 – FDA: Zimmer Biomet, Inc.- Orthopedic Salvage System (OSS) Modular Arthrodesis 0 Degree Locking Collar, Model Number CP260600; 15/05/2018 – Zimmer Adds LaSalle Hotel, Exits Atmos: 13F; 02/04/2018 – Zimmer Biomet Announces FDA Clearance of the Comprehensive® Augmented Baseplate for Shoulder Reconstruction; 14/03/2018 – FDA: Zimmer Biomet, Inc.- ACE Trochanteric Nail System TROCH NAIL ST 11X180 125DG STRL TROCH NAIL ST 11X180 130DG STRL TROC; 13/04/2018 – Zimmer Biomet: Katarzyna Mazur-Hofsaess, President, Europe, Middle East and Africa, to Resign Her Positions With Firm and Affiliates; 06/03/2018 – Zimmer Biomet Exhibits Product and Service Innovations at AAOS 2018; 14/03/2018 – FDA: Zimmer Biomet, Inc.- PRCT MIS CR MOB PLT SZ 4 L® PRCT MIS CR MOB PLT SZ 5 L® PRCT MIS CR MOB PLT SZ 6 L® PRCT MIS CR; 15/05/2018 – Zimmer Biomet Presenting at Bank of America Conference Tomorrow; 14/03/2018 – FDA: Zimmer Biomet, Inc.- ACE Trochanteric Nail System TROCH NAIL ST 13X180 125DG STRL TROCH NAIL ST 13X180 130DG STRL TROC

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, makes, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $25.20 billion. It operates through four divisions: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic , and Dental. It currently has negative earnings. The firm provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

More notable recent Zimmer Biomet Holdings, Inc. (NYSE:ZBH) news were published by: Seekingalpha.com which released: “Zimmer Biomet beats Q4 consensus – Seeking Alpha” on February 01, 2019, also Gurufocus.com with their article: “Weekly CEO Buys Highlight – GuruFocus.com” published on February 11, 2019, Seekingalpha.com published: “Zimmer Biomet recalls certain lots of spinal fusion and long bone stimulators – Seeking Alpha” on November 27, 2018. More interesting news about Zimmer Biomet Holdings, Inc. (NYSE:ZBH) were released by: Benzinga.com and their article: “Argus Drops Bullish Zimmer Biomet (NYSE:ZBH) Thesis On Manufacturing, Supply, Sales Worries – Benzinga” published on June 22, 2018 as well as Seekingalpha.com‘s news article titled: “Insider Weekends: Chairman Of Kinder Morgan Steps Up Insider Purchases – Seeking Alpha” with publication date: February 11, 2019.

Among 9 analysts covering Zimmer Biomet Holdings (NYSE:ZBH), 4 have Buy rating, 2 Sell and 3 Hold. Therefore 44% are positive. Zimmer Biomet Holdings had 12 analyst reports since August 16, 2018 according to SRatingsIntel. On Monday, October 29 the stock rating was maintained by Citigroup with “Neutral”. The rating was maintained by Jefferies on Monday, October 29 with “Buy”. The rating was maintained by Barclays Capital with “Underweight” on Monday, October 29. As per Wednesday, January 2, the company rating was upgraded by Citigroup. The stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has “Overweight” rating given on Wednesday, January 2 by Morgan Stanley. Morgan Stanley maintained it with “Overweight” rating and $149 target in Thursday, October 11 report. On Wednesday, December 19 the stock rating was downgraded by JP Morgan to “Neutral”.

Investors sentiment increased to 0.82 in 2018 Q3. Its up 0.12, from 0.7 in 2018Q2. It is positive, as 34 investors sold Corning Incorporated shares while 312 reduced holdings. 105 funds opened positions while 177 raised stakes. 536.85 million shares or 3.23% less from 554.76 million shares in 2018Q2 were reported. Putnam Invests Llc invested in 57,067 shares. Family Cap Trust owns 0.03% invested in Corning Incorporated (NYSE:GLW) for 2,200 shares. 88,750 were reported by Paradigm Asset Management Ltd Liability Com. Pennsylvania stated it has 0.16% in Corning Incorporated (NYSE:GLW). Cohen Klingenstein Limited Company has 0.43% invested in Corning Incorporated (NYSE:GLW) for 96,650 shares. 66,471 are held by Commonwealth Of Pennsylvania Pub School Empls Retrmt Systems. Marathon Management reported 1.28% stake. Earnest Ptnrs Limited Liability reported 0.06% of its portfolio in Corning Incorporated (NYSE:GLW). Bowen Hanes Inc reported 1.57 million shares stake. Ontario Teachers Pension Plan Board reported 0.04% of its portfolio in Corning Incorporated (NYSE:GLW). Cambridge Advsr accumulated 49,091 shares. Smithfield Trust holds 5,612 shares or 0.02% of its portfolio. Valley National Advisers holds 0.01% or 710 shares. Advsr Asset Management Inc stated it has 0.11% of its portfolio in Corning Incorporated (NYSE:GLW). Baldwin Brothers Ma invested in 0.01% or 1,520 shares.

Corning Incorporated manufactures and sells specialty glasses, ceramics, and related materials in North America, the Asia Pacific, Europe, and internationally. The company has market cap of $26.82 billion. The firm operates through five divisions: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. It has a 30.04 P/E ratio. The Display Technologies segment makes glass substrates for liquid crystal displays used in LCD televisions, notebook computers, and flat panel desktop monitors.

Among 2 analysts covering Corning (NYSE:GLW), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Corning had 3 analyst reports since September 14, 2018 according to SRatingsIntel. Citigroup maintained it with “Buy” rating and $38 target in Wednesday, October 24 report. The rating was upgraded by Citigroup on Friday, September 14 to “Buy”. The company was maintained on Wednesday, October 24 by UBS.

Since August 27, 2018, it had 0 insider buys, and 10 selling transactions for $5.42 million activity. On Monday, August 27 the insider Musser Eric S sold $609,626. Shares for $395,851 were sold by STEVERSON LEWIS A. McRae Lawrence D sold $1.11 million worth of stock or 30,667 shares. Shares for $4,623 were sold by Morse David L on Tuesday, November 20. Pambianchi Christine M sold $33,655 worth of stock or 1,000 shares. RIEMAN DEBORAH sold $143,071 worth of stock or 4,430 shares.

More news for Corning Incorporated (NYSE:GLW) were recently published by: Fool.com, which released: “Is Corning a Buy? – The Motley Fool” on February 08, 2019. Benzinga.com‘s article titled: “Corning Incorporated (NYSE:GLW) – Will Foxconn Follow Through With Wisconsin Factory? – Benzinga” and published on February 05, 2019 is yet another important article.

Corning Incorporated (NYSE:GLW) Institutional Positions Chart